Suhendan Ekmekcioglu

7PUBLICATIONS
66CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 21, 2026
Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study.

|Feb 28, 2024
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies.

Bofei Wang, Patrick K Reville, Mhd Yousuf Yassouf

|Aug 02, 2023
Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion.

Yasunari Fukuda, Sun-Hee Kim, Matias A Bustos

|May 02, 2022
Correction: Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.

Yasunari Fukuda, Matias A Bustos, Sung-Nam Cho

|Feb 05, 2022
Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.

Yasunari Fukuda, Matias A Bustos, Sung-Nam Cho

|Jan 09, 2021
Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells.

Rebaz Ahmed, Ranganayaki Muralidharan, Akhil Srivastava

Pageof 2

Frequent Collaborators

5 joint publications

Jared K Burks

2 joint publications

Jason Roszik

2 joint publications

Sung-Nam Cho

2 joint publications

Victor M Lopez